SMAD3 and neoplasm: The tumor suppressor function of ARID1A through collaboration with TP53 is disrupted by loss of ARID1A and this change could have led to disruption in TP53-regulated genes such as CDKN1A and SMAD3, which were all inhibited in IPA analysis.